Squarepoint’s QuidelOrtho QDEL Stock Holding History

Squarepoint’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,500	Closed	-$787K	–	4147
2023 Q2	$787K	Buy	+9,500	New	+$832K	﹤0.01%	2343

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Squarepoint's QDEL Position: Q3 2025 in Review

Squarepoint sold out of QuidelOrtho (QDEL) in Q3 2025, closing a stake of 23,774 shares — an estimated $685K sold.

Squarepoint first reported a position in QDEL in Q2 2017 and held it in 20 quarters. The position peaked at $4.4M in Q2 2021. 254 funds tracked by Wall St. Rank hold QDEL as of Q3 2025.

Squarepoint reported no remaining QuidelOrtho position as of Q3 2025 after selling out during the quarter.
Squarepoint sold 23,774 QuidelOrtho shares in Q3 2025, an estimated $685K.
Squarepoint first reported a position in QuidelOrtho in Q2 2017 and held it in 20 quarters.
Squarepoint's QuidelOrtho position peaked at $4.4M in Q2 2021.
254 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.